Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP414431.RAcBcjevmVLH-14i-EWl8H-z-qeOV33lbkcFfPFRjKD7k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP414431.RAcBcjevmVLH-14i-EWl8H-z-qeOV33lbkcFfPFRjKD7k130_assertion type Assertion NP414431.RAcBcjevmVLH-14i-EWl8H-z-qeOV33lbkcFfPFRjKD7k130_head.
- NP414431.RAcBcjevmVLH-14i-EWl8H-z-qeOV33lbkcFfPFRjKD7k130_assertion description "[To further characterize RCC T-cell responses and identify relevant RCC-associated antigens, we did a detailed analysis of CD8+ T-cell responses in two vaccinated RCC patients who generated the greatest magnitude of DTH response and also displayed a strong clinical response to vaccination (>90% reduction in metastatic tumor volume).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414431.RAcBcjevmVLH-14i-EWl8H-z-qeOV33lbkcFfPFRjKD7k130_provenance.
- NP414431.RAcBcjevmVLH-14i-EWl8H-z-qeOV33lbkcFfPFRjKD7k130_assertion evidence source_evidence_literature NP414431.RAcBcjevmVLH-14i-EWl8H-z-qeOV33lbkcFfPFRjKD7k130_provenance.
- NP414431.RAcBcjevmVLH-14i-EWl8H-z-qeOV33lbkcFfPFRjKD7k130_assertion SIO_000772 15705910 NP414431.RAcBcjevmVLH-14i-EWl8H-z-qeOV33lbkcFfPFRjKD7k130_provenance.
- NP414431.RAcBcjevmVLH-14i-EWl8H-z-qeOV33lbkcFfPFRjKD7k130_assertion wasDerivedFrom befree-20140225 NP414431.RAcBcjevmVLH-14i-EWl8H-z-qeOV33lbkcFfPFRjKD7k130_provenance.
- NP414431.RAcBcjevmVLH-14i-EWl8H-z-qeOV33lbkcFfPFRjKD7k130_assertion wasGeneratedBy ECO_0000203 NP414431.RAcBcjevmVLH-14i-EWl8H-z-qeOV33lbkcFfPFRjKD7k130_provenance.